Group 1 - Cambrian's private placement price is set at 1195.02 yuan per share, with a total fundraising amount of 3.985 billion yuan [4] - Bee Assistant plans to raise no more than 984 million yuan for projects including cloud terminal computing power center and IoT terminal upgrades [5] - Kexing Pharmaceutical is planning to issue H-shares and list on the Hong Kong Stock Exchange [6] - Three squirrels have received approval from the China Securities Regulatory Commission for H-share issuance, with plans to issue up to 81.5483 million shares [7] - Ruiming Technology has submitted an application for H-share issuance to the Hong Kong Stock Exchange [8] Group 2 - Binhua Co. plans to invest 1.421 billion yuan in an integrated project for wind, solar, and energy storage [9] - Sains plans to invest no more than 300 million yuan in the expansion of its selection agent project [10] Group 3 - Hunan YN reports no significant changes in its internal and external operating environment [11] - Electric Power Investment has had its major asset replacement review suspended by the Shenzhen Stock Exchange due to expired financial documents [12] - Guanzhong Ecological is in the planning stage for acquiring a 51% stake in Hangzhou Actuary [13][14] Group 4 - Aima Technology's subsidiary is transferring production capacity and ceasing operations due to strategic adjustments [17] - Fosun Pharma's subsidiary has received approval for clinical trials of a new drug [18] - SAIC Group's subsidiary plans to invest 666 million yuan in the restructuring of SAIC Hongyan [19] Group 5 - Hanwei Technology plans to sell 65% of Hanwei Zhiyuan for approximately 440 million yuan [20] - Xingtong Co. has been awarded new capacity for coastal inter-provincial bulk liquid hazardous goods transportation [21][22] Group 6 - EVE Battery Investment received a cash dividend of 375 million HKD from its associate company [23] - Shanmei International's chairman has resigned due to work changes [24] - Weiye Co.'s chairman has resigned for personal reasons [25] Group 7 - Jiao Da Sino's chairman has been placed under detention [26] - Duorui Pharmaceutical is planning a change in control, leading to a stock suspension [27][28] - *ST Zhengping's stock has been suspended for investigation due to abnormal price fluctuations [29] Group 8 - Zhenray Technology's chairman has had detention measures lifted [30] - Shiming Technology's chairman has had detention measures changed to a warning [31] - Nanxin Pharmaceutical is under investigation by the CSRC for suspected violations in annual report disclosures [32] Group 9 - Daqian Ecology's shareholder plans to reduce holdings by up to 3% [33] - Rundar Medical's shareholders plan to reduce holdings by up to 2.99% [34][35] - Saili Medical's shareholder plans to reduce holdings by up to 2% [36] Group 10 - Huaxin Environmental plans to repurchase shares for 40 to 80 million yuan [37] - Tianyong Intelligent has been awarded a contract worth 58.8 million yuan for an engine assembly line project [38] - Zhongwu Drone has signed a significant contract worth 615 million yuan for drone systems [39]

Group 1 - Company Chairman Li Wei has been placed under detention, and Vice General Manager Zhang Min will assume his responsibilities [1][2] - The company held a board meeting on September 29, 2025, to authorize Zhang Min to act as the Chairman and legal representative until Li Wei resumes his duties or a new appointment is made [2] - The company maintains that its operational management is normal and that other board members and senior management are fulfilling their roles [2] Group 2 - Company revenue for the first half of the year was 128 million yuan, a year-on-year decline of 18.48%, with net profit attributable to shareholders at 12.19 million yuan, down 51.64% [4] - The company has consistently maintained annual revenue around 300 million yuan [4] - Founded in 2001, the company specializes in rail transit, focusing on control system equipment such as responder systems and train signal devices [4]

北京商报讯（记者 马换换 王蔓蕾）9月30日晚间，交大思诺（300851）披露公告称，公司于近日收到公 司董事长李伟家属的通知，其收到由天津市滨海新区监察委员会签发的关于李伟的《留置通知书》，李 伟被实施留置。 交大思诺表示，鉴于公司董事长李伟暂无法履行董事长职责，为了保证公司董事会正常运作和经营决策 的顺利开展，维护公司经营和治理的稳定性，公司于9月29日召开第四届董事会第八次会议，同意由公 司董事、副总经理张民代为履行公司董事长、法定代表人的全部职责及李伟在公司董事会相关委员会成 员的职责，同时授权张民代表公司对外签署重大合同、招投标文件及定期报告等相关文件。代行职责的 期限自推举之日起至李伟恢复履行职责或公司选举产生新任相关职务人员之日止。公司拥有完善的治理 结构及内部控制机制，日常经营管理由公司高管团队负责。目前公司生产经营管理情况一切正常，其他 董事、高级管理人员均正常履职，董事会依法履行相关职责。 ...

Group 1 - Cambrian's private placement price is set at 1195.02 yuan per share, with a total fundraising amount of 3.985 billion yuan [2] - Bee Assistant plans to raise up to 984 million yuan for projects including cloud terminal computing power center and IoT terminal upgrades [3] - Kexing Pharmaceutical is planning to issue H-shares and list on the Hong Kong Stock Exchange [4] Group 2 - Three squirrels received approval from the China Securities Regulatory Commission for H-share issuance, planning to issue up to 81.5483 million shares [5] - Ruiming Technology has submitted an application for H-share issuance to the Hong Kong Stock Exchange [6] - Binhua Co. plans to invest 1.421 billion yuan in an integrated project for wind and solar energy [7] Group 3 - Sainz's subsidiary plans to invest up to 300 million yuan in the expansion of selection and extraction agents [8] - Hunan YN reported no significant changes in its internal and external operating environment [9] - Electric Power Investment plans to restructure assets and has received a notice from the Shenzhen Stock Exchange to suspend review [10] Group 4 - Guanzhong Ecology is in the planning stage to acquire 51% of Hangzhou Actuary [11] - Aima Technology announced the transfer and suspension of production capacity at its subsidiary in Guangdong [12] - Fosun Pharma's subsidiary received approval for clinical trials of a new drug [13] Group 5 - EVE Battery Investment received a cash dividend of 375 million HKD from its indirect associate, Simoer International [14] - Shanmei International announced a change in its board leadership due to personnel changes [15] - Weiye Co. announced the resignation of its chairman for personal reasons [16] Group 6 - Jiaoda Sinuo's chairman is under detention, and the company has appointed a new acting chairman [17] - Duorui Pharmaceutical is planning a change in control, leading to a stock suspension [18] - ST Zhengping's stock price has seen an abnormal increase, leading to a suspension for investigation [19] Group 7 - Daqian Ecology's shareholder plans to reduce its stake by up to 3% [20] - Rundat Medical's shareholders plan to collectively reduce their stake by up to 2.99% [21] - Seli Medical's shareholder plans to reduce its stake by up to 2% [22] Group 8 - Tianyong Intelligent has been awarded a contract worth 58.8 million yuan for an engine assembly line project [23] - Zhongwu Drone signed a significant contract worth 615 million yuan for drone systems [24]

Core Points - The chairman of the company, Li Wei, has been placed under detention by the Tianjin Binhai New Area Supervisory Committee, temporarily unable to fulfill his duties [1] - To ensure normal operations and decision-making, the board of directors appointed Zhang Min, the deputy general manager, to act as chairman and legal representative until Li Wei resumes his duties or a new appointment is made [1] - The company maintains a robust governance structure and internal control mechanisms, with daily operations managed by the executive team, and all other board members and senior management are performing their duties normally [1] Company Operations - The company held a board meeting on September 29, 2025, to address the situation and ensure continuity in leadership [1] - As of the announcement date, the company has not received further updates regarding the progress or conclusion of the detention matter [1] - The company will continue to monitor the situation and will fulfill its information disclosure obligations as required by relevant laws and regulations [1]

9月30日晚，交大思诺公告称，近日收到公司董事长李伟家属的通知，其收到由天津市滨海新区监察委 员会签发的关于李伟的《留置通知书》，李伟被实施留置，暂无法履行董事长职责。 截至本公告披露日，公司尚未知悉上述事项的进展及结论。公司将持续关注后续进展，对相关工作进行 妥善安排，并按照有关法律、法规的规定和要求，及时履行信息披露义务。 交大思诺表示，为保证公司正常运作和经营决策的顺利开展，维护公司经营和治理的稳定性，公司于 2025年9月29日召开董事会，同意由董事、副总经理张民代为履行董事长、法定代表人的全部职责及 李伟在公司董事会相关委员会成员的职责。代行期限自推举之日起至李伟恢复履行职责或公司选举产生 新任相关职务人员之日止。 交大思诺表示，公司拥有完善的治理结构及内部控制机制，日常经营管理由公司高管团队负责。目前公 司生产经营管理情况一切正常，其他董事、高级管理人员均正常履职，董事会依法履行相关职责。 ...

智通财经APP讯，交大思诺(300851.SZ)发布公告，公司于近日收到公司董事长李伟先生家属的通知，其 收到由天津市滨海新区监察委员会签发的关于李伟先生的《留置通知书》，李伟先生被实施留置。 ...

(本文来自第一财经) 交大思诺公告，公司于近日收到公司董事长李伟家属的通知，其收到由天津市滨海新区监察委员会签发 的关于李伟的《留置通知书》，李伟被实施留置。公司于2025年9月29日召开第四届董事会第八次会 议，同意由公司董事、副总经理张民代为履行公司董事长、法定代表人的全部职责及李伟在公司董事会 相关委员会成员的职责，同时授权张民代表公司对外签署重大合同、招投标文件及定期报告等相关文 件。代行职责的期限自推举之日起至李伟恢复履行职责或公司选举产生新任相关职务人员之日止。目前 公司生产经营管理情况一切正常，其他董事、高级管理人员均正常履职，董事会依法履行相关职责。 ...

格隆汇9月30日丨交大思诺(300851.SZ)公布，近日收到公司董事长李伟先生家属的通知，其收到由天津 市滨海新区监察委员会签发的关于李伟先生的《留置通知书》，李伟先生被实施留置。鉴于公司董事长 李伟先生暂无法履行董事长职责，为了保证公司董事会正常运作和经营决策的顺利开展，维护公司经营 和治理的稳定性，公司于2025年9月29日召开第四届董事会第八次会议，同意由公司董事、副总经理张 民先生代为履行公司董事长、法定代表人的全部职责及李伟先生在公司董事会相关委员会成员的职责， 同时授权张民先生代表公司对外签署重大合同、招投标文件及定期报告等相关文件。代行职责的期限自 推举之日起至李伟先生恢复履行职责或公司选举产生新任相关职务人员之日止。 ...

北京交大思诺科技股份有限公司 关于公司重大事项的公告 本公司及董事会全体成员保证信息披露内容的真实、准确和完整，没有虚假 记载、误导性陈述或重大遗漏。 北京交大思诺科技股份有限公司（以下简称"公司"）于近日收到公司董事 长李伟先生家属的通知，其收到由天津市滨海新区监察委员会签发的关于李伟先 生的《留置通知书》，李伟先生被实施留置。 鉴于公司董事长李伟先生暂无法履行董事长职责，为了保证公司董事会正 常运作和经营决策的顺利开展，维护公司经营和治理的稳定性，公司于 2025 年 9 月 29 日召开第四届董事会第八次会议，同意由公司董事、副总经理张民先生 代为履行公司董事长、法定代表人的全部职责及李伟先生在公司董事会相关委员 会成员的职责，同时授权张民先生代表公司对外签署重大合同、招投标文件及定 期报告等相关文件。代行职责的期限自推举之日起至李伟先生恢复履行职责或公 司选举产生新任相关职务人员之日止。 公司拥有完善的治理结构及内部控制机制，日常经营管理由公司高管团队 负责。目前公司生产经营管理情况一切正常，其他董事、高级管理人员均正常履 职，董事会依法履行相关职责。 截至本公告披露日，公司尚未知悉上述事项的进展及结 ...